Información del autor
Documentos disponibles escritos por este autor (3)
Añadir el resultado a su cesta Hacer una sugerencia Refinar búsqueda
texto impreso
Fentress, M. ; Ugarte-Gil, C. ; Cervantes, M. ; Rivas, D. ; Moore, D. ; Caliguiri, P. ; Bergman, K. ; Noazin, S. ; Padovani, A. ; Gilman, R.H. | American Society of Tropical Medicine and Hygiene | 2020-12-14T16:06:22ZLung ultrasound (LUS) is highly portable and has excellent diagnostic accuracy for pneumonia compared with conventional radiography, but the literature on its use in pulmonary tuberculosis (PTB) is limited. This study characterized LUS lesions i[...]texto impreso
Ugarte-Gil, C. ; Pearson, F. ; Moore, D. ; Critchley, J. ; van Crevel, R. | Oxford University Press | 2019-08-08T15:23:45ZWe thank Drs Yates and Barr for their valuable comments. In our article [1], we were not attempting to assess the extent to which dysglycemia is causally associated with tuberculosis (TB). A number of prospective studies exist, among a body of e[...]texto impreso
Trollip, A. P. ; Moore, D. ; Coronel, J. ; Caviedes, L. ; Klages, S. ; Victor, T. ; Romancenco, E. ; Crudu, V. ; Ajbani, K. ; Vineet, V. P. ; Rodrigues, C. ; Jackson, R. L. ; Eisenach, K. ; Garfein, R. S. ; Rodwell, T. C. ; Desmond, E. ; Groessl, E. J. ; Ganiats, T. G. ; Catanzaro, A. | International Union Against Tuberculosis and Lung Disease | 2020-06-10T18:11:35ZOBJECTIVE: To establish breakpoint concentrations for the fluoroquinolones (moxifloxacin [MFX] and ofloxacin [OFX]) and injectable second-line drugs (amikacin [AMK], kanamycin [KM] and capreomycin [CPM]) using the microscopic observation drug su[...]
